Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Assets: 2011-2025

Historic Assets for SRx Health Solutions (SRXH) over the last 15 years, with FY2025 value amounting to $8.4 million.

  • SRx Health Solutions' Assets fell 7511.55% to $8.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $73.5 million, marking a year-over-year decrease of 702.77%. This contributed to the annual value of $8.4 million for FY2025, which is N/A changed from last year.
  • SRx Health Solutions' Assets amounted to $8.4 million in FY2025.
  • In the past 5 years, SRx Health Solutions' Assets ranged from a high of $74.7 million in FY2021 and a low of $8.4 million during FY2025
  • In the last 5 years, SRx Health Solutions' Assets had a median value of $16.7 million in 2023 and averaged $30.9 million.
  • As far as peak fluctuations go, SRx Health Solutions' Assets soared by 4566.95% in 2021, and later plummeted by 5672.51% in 2023.
  • SRx Health Solutions' Assets (Annual) stood at $74.7 million in 2021, then plummeted by 48.2% to $38.7 million in 2022, then crashed by 56.73% to $16.7 million in 2023, then decreased by 5.59% to $15.8 million in 2024, then crashed by 46.83% to $8.4 million in 2025.
  • Its Assets was $8.4 million in FY2025, compared to $15.8 million in FY2024 and $16.7 million in FY2023.